_id

690db2c9ccc777a4e85d0c95

Ticker

ATRA

Name

Atara Biotherapeutics Inc

Exchange

NASDAQ

Address

1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.atarabio.com

Description

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Last Close

16.83

Volume

62938

Current Price

17.82

Change

5.882352941176483

Last Updated

2025-11-28T12:31:49.286Z

Image

data:image/webp;base64,UklGRj4BAABXRUJQVlA4IDIBAACQBwCdASpAAEAAPrVUo02nJKMiKBQKAOAWiWMAI8A3hs2gNIEywSlOQ8VOSqk56nn4yWg1HJ/eLrJqZ8XXo9MkwXizsAAA/vikDnp4mnAuI4ADm0c4cdlT4uNbYcYDWn/Cz4oZyqv/v43s+HXZzhAc+9QMpnVaCFMLr5qU7l55S8HCqGuz5R0mHvD4KVlOEhcQt8UmhtbWVYMBaAaXL/QOn3GcGE/pXv+pWmHsY4gMzFuBag57jH0ydKZYugB+dm3DxqKLPOZarkjva8+IfWTtisO9R5S6w7dFc8XKbaglj3/P+wJ46NgmcV6FFe3a9dZGxuDtNmJX2V7hnZuPtQ1DLR6c3tuR34njd2PH0TLsEk1X3nFCm1aSnYKD+Dun773LQGh4Xtn53cs3ZJyMEkQAAAA=

Ipo Date

2014-10-16T00:00:00.000Z

Market Cap

107144088

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9083333333333333

Sentiment Sources

3

Rating

4.6

Target Price

16.3333

Strong Buy

4

Buy

0

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

3453000

Cost Of Revenue

115000

Gross Profit

3338000

Operating Expenses

6885000

Operating Income

-3547000

Interest Expense

909000

Pretax Income

-4275000

Net Income

-4303000

Eps

-0.3172368033028605

Dividends Per Share

-

Shares Outstanding

7210235

Income Tax Expense

28000

EBITDA

-3330000

Operating Margin

-102.72227048942948

Total Other Income Expense Net

-728000

Cash

5742000

Short Term Investments

7970000

Receivables

1913000

Inventories

0

Total Current Assets

18432000

Property Plant Equipment

10854000

Total Assets

30167000

Payables

318000

Short Term Debt

11623000

Long Term Debt

-

Total Liabilities

66801000

Equity

-36634000

Depreciation

36000

Change In Working Capital

-7877000

Cash From Operations

-9787000

Capital Expenditures

0

Cash From Investing

-2421000

Cash From Financing

1046999

Net Change In Cash

-11161000

PE

5.1958

PB

-6.231427635529835

ROE

11.745919091554294

ROA

-14.263930785295189

FCF

-9787000

Fcf Percent

-2.8343469446857803

Piotroski FScore

0

Health Score

23

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

1.5

Growth Investing Score

1.5

Momentum Investing Score

7

Net Net Investing Score

0.5

Quality Investing Score

1.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

3453000

Quarters > 0 > income Statement > cost Of Revenue

115000

Quarters > 0 > income Statement > gross Profit

3338000

Quarters > 0 > income Statement > operating Expenses

6885000

Quarters > 0 > income Statement > operating Income

-3547000

Quarters > 0 > income Statement > interest Expense

909000

Quarters > 0 > income Statement > pretax Income

-4275000

Quarters > 0 > income Statement > net Income

-4303000

Quarters > 0 > income Statement > eps

-0.3172368033028605

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

13564000

Quarters > 0 > income Statement > income Tax Expense

28000

Quarters > 0 > income Statement > EBITDA

-3330000

Quarters > 0 > income Statement > operating Margin

-102.72227048942948

Quarters > 0 > income Statement > total Other Income Expense Net

-728000

Quarters > 0 > balance Sheet > cash

5742000

Quarters > 0 > balance Sheet > short Term Investments

7970000

Quarters > 0 > balance Sheet > receivables

1913000

Quarters > 0 > balance Sheet > inventories

0

Quarters > 0 > balance Sheet > total Current Assets

18432000

Quarters > 0 > balance Sheet > property Plant Equipment

10854000

Quarters > 0 > balance Sheet > total Assets

30167000

Quarters > 0 > balance Sheet > payables

318000

Quarters > 0 > balance Sheet > short Term Debt

11623000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

66801000

Quarters > 0 > balance Sheet > equity

-36634000

Quarters > 0 > cash Flow > net Income

-4303000

Quarters > 0 > cash Flow > depreciation

36000

Quarters > 0 > cash Flow > change In Working Capital

-7877000

Quarters > 0 > cash Flow > cash From Operations

-9787000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-2421000

Quarters > 0 > cash Flow > cash From Financing

1046999

Quarters > 0 > cash Flow > net Change In Cash

-11161000

Quarters > 0 > ratios > PE

-0.3172368033028605

Quarters > 0 > ratios > PB

-6.231427635529835

Quarters > 0 > ratios > ROE

11.745919091554294

Quarters > 0 > ratios > ROA

-14.263930785295189

Quarters > 0 > ratios > FCF

-9787000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-2.8343469446857803

Quarters > 0 > health Score

23

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

17575000

Quarters > 1 > income Statement > cost Of Revenue

554000

Quarters > 1 > income Statement > gross Profit

17021000

Quarters > 1 > income Statement > operating Expenses

13824000

Quarters > 1 > income Statement > operating Income

3197000

Quarters > 1 > income Statement > interest Expense

972000

Quarters > 1 > income Statement > pretax Income

2390000

Quarters > 1 > income Statement > net Income

2387000

Quarters > 1 > income Statement > eps

0.19390739236393176

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

12310000

Quarters > 1 > income Statement > income Tax Expense

3000

Quarters > 1 > income Statement > EBITDA

3598000

Quarters > 1 > income Statement > operating Margin

18.190611664295876

Quarters > 1 > income Statement > total Other Income Expense Net

-807000

Quarters > 1 > balance Sheet > cash

16903000

Quarters > 1 > balance Sheet > short Term Investments

5420000

Quarters > 1 > balance Sheet > receivables

0

Quarters > 1 > balance Sheet > inventories

0

Quarters > 1 > balance Sheet > total Current Assets

24772000

Quarters > 1 > balance Sheet > property Plant Equipment

11203000

Quarters > 1 > balance Sheet > total Assets

36902000

Quarters > 1 > balance Sheet > payables

1762000

Quarters > 1 > balance Sheet > short Term Debt

2242000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

71943000

Quarters > 1 > balance Sheet > equity

-35041000

Quarters > 1 > cash Flow > net Income

2387000

Quarters > 1 > cash Flow > depreciation

236000

Quarters > 1 > cash Flow > change In Working Capital

-12771000

Quarters > 1 > cash Flow > cash From Operations

-7318000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-5070000

Quarters > 1 > cash Flow > cash From Financing

15304000

Quarters > 1 > cash Flow > net Change In Cash

2916000

Quarters > 1 > ratios > PE

0.19390739236393176

Quarters > 1 > ratios > PB

-5.912425444479323

Quarters > 1 > ratios > ROE

-6.8120202049028284

Quarters > 1 > ratios > ROA

6.468484093003089

Quarters > 1 > ratios > FCF

-7318000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.4163869132290185

Quarters > 1 > health Score

36

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

98149000

Quarters > 2 > income Statement > cost Of Revenue

20439000

Quarters > 2 > income Statement > gross Profit

77710000

Quarters > 2 > income Statement > operating Expenses

38908000

Quarters > 2 > income Statement > operating Income

38802000

Quarters > 2 > income Statement > interest Expense

1017000

Quarters > 2 > income Statement > pretax Income

38010000

Quarters > 2 > income Statement > net Income

38010000

Quarters > 2 > income Statement > eps

3.5029029582526956

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

10851000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

40822000

Quarters > 2 > income Statement > operating Margin

39.53377008425964

Quarters > 2 > income Statement > total Other Income Expense Net

-792000

Quarters > 2 > balance Sheet > cash

13841000

Quarters > 2 > balance Sheet > short Term Investments

0

Quarters > 2 > balance Sheet > receivables

8875000

Quarters > 2 > balance Sheet > inventories

0

Quarters > 2 > balance Sheet > total Current Assets

27182000

Quarters > 2 > balance Sheet > property Plant Equipment

32012000

Quarters > 2 > balance Sheet > total Assets

62038000

Quarters > 2 > balance Sheet > payables

1384000

Quarters > 2 > balance Sheet > short Term Debt

28321000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

117110000

Quarters > 2 > balance Sheet > equity

-55072000

Quarters > 2 > cash Flow > net Income

38010000

Quarters > 2 > cash Flow > depreciation

1795000

Quarters > 2 > cash Flow > change In Working Capital

-82113000

Quarters > 2 > cash Flow > cash From Operations

-28138000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

17199000

Quarters > 2 > cash Flow > cash From Financing

-250000

Quarters > 2 > cash Flow > net Change In Cash

-11189000

Quarters > 2 > ratios > PE

3.5029029582526956

Quarters > 2 > ratios > PB

-3.3160649694944797

Quarters > 2 > ratios > ROE

-69.0187391051714

Quarters > 2 > ratios > ROA

61.268899706631416

Quarters > 2 > ratios > FCF

-28138000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.28668656838072726

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

32753000

Quarters > 3 > income Statement > cost Of Revenue

6795000

Quarters > 3 > income Statement > gross Profit

25958000

Quarters > 3 > income Statement > operating Expenses

38161000

Quarters > 3 > income Statement > operating Income

-12203000

Quarters > 3 > income Statement > interest Expense

1017000

Quarters > 3 > income Statement > pretax Income

-12712000

Quarters > 3 > income Statement > net Income

-12693000

Quarters > 3 > income Statement > eps

-1.1873713751169317

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

10690000

Quarters > 3 > income Statement > income Tax Expense

-19000

Quarters > 3 > income Statement > EBITDA

-10595000

Quarters > 3 > income Statement > operating Margin

-37.25765578725613

Quarters > 3 > income Statement > total Other Income Expense Net

-509000

Quarters > 3 > balance Sheet > cash

25030000

Quarters > 3 > balance Sheet > short Term Investments

17466000

Quarters > 3 > balance Sheet > receivables

1482000

Quarters > 3 > balance Sheet > inventories

10655000

Quarters > 3 > balance Sheet > total Current Assets

64894000

Quarters > 3 > balance Sheet > property Plant Equipment

41101000

Quarters > 3 > balance Sheet > total Assets

109098000

Quarters > 3 > balance Sheet > payables

4367000

Quarters > 3 > balance Sheet > short Term Debt

13917000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

206381000

Quarters > 3 > balance Sheet > equity

-97283000

Quarters > 3 > cash Flow > net Income

-12693000

Quarters > 3 > cash Flow > depreciation

1100000

Quarters > 3 > cash Flow > change In Working Capital

-22405000

Quarters > 3 > cash Flow > cash From Operations

-24471000

Quarters > 3 > cash Flow > capital Expenditures

90000

Quarters > 3 > cash Flow > cash From Investing

3376000

Quarters > 3 > cash Flow > cash From Financing

-328000

Quarters > 3 > cash Flow > net Change In Cash

-21423000

Quarters > 3 > ratios > PE

-1.1873713751169317

Quarters > 3 > ratios > PB

-1.849374505309252

Quarters > 3 > ratios > ROE

13.047500591059075

Quarters > 3 > ratios > ROA

-11.634493757905737

Quarters > 3 > ratios > FCF

-24561000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-0.7498855066711446

Quarters > 3 > health Score

24

Valuation > metrics > PE

5.1958

Valuation > metrics > PB

-6.231427635529835

Valuation > final Score

70

Valuation > verdict

48.0% Undervalued

Profitability > metrics > ROE

11.745919091554294

Profitability > metrics > ROA

-23.34526909722222

Profitability > metrics > Net Margin

-1.2461627570228786

Profitability > final Score

23

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-3.902090209020902

Risk > final Score

14

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.543589314127795

Liquidity > metrics > Quick Ratio

1.543589314127795

Liquidity > final Score

89

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

50

Prev Profitabilities > 0

49

Prev Profitabilities > 1

60

Prev Profitabilities > 2

26

Prev Risks > 0

43

Prev Risks > 1

70

Prev Risks > 2

-18

Prev Liquidities > 0

100

Prev Liquidities > 1

56

Prev Liquidities > 2

100

Updated At

2025-12-12T14:06:21.635Z